FDA.reportPublic FDA data

kygevvi 2 GM / 2 GM Powder for Oral Solution

RxCUI
2737541
RxNorm name
kygevvi 2 GM / 2 GM Powder for Oral Solution
Display name
kygevvi 2 GM / 2 GM Powder for Oral Solution
Full name
kygevvi 2 GM / 2 GM Powder for Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
7d5ce670-9314-4fd7-8b0a-1447910dcf9ekygevvi 2 GM / 2 GM Powder for Oral Solution [PSN] · doxecitine 2000 MG / doxribtimine 2000 MG Powder for Oral Solution [Kygevvi] [SBD] · Kygevvi (doxecitine 2 GM / doxribtimine 2 GM) Powder for Oral Solution [SY]33These highlights do not include all the information needed to use KYGEVVI safely and effectively. See full prescribing information for KYGEVVI. KYGEVVI (doxecitine and doxribtimine) powder, for oral solution Initial U.S. Approval: 202520251110